These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11028230)

  • 1. The influence of diluent on the release of theophylline from hydrophilic matrix tablets.
    Pina ME; Veiga F
    Drug Dev Ind Pharm; 2000 Oct; 26(10):1125-8. PubMed ID: 11028230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
    Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
    Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
    Chowdary KP; Nalluri BN
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
    Moore E; Bergamo R; Casella R
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin.
    Ghorab MK; Adeyeye MC
    Pharm Dev Technol; 2001 Aug; 6(3):305-14. PubMed ID: 11485172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of theophylline-hydroxypropylmethylcellulose matrices using supercritical antisolvent precipitation: a preliminary study.
    Moneghini M; Perissutti B; Kikic I; Grassi M; Cortesi A; Princivalle F
    Drug Dev Ind Pharm; 2006 Jan; 32(1):39-52. PubMed ID: 16455603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of fibroin in controlled release tablets containing theophylline.
    Katayama H; Issiki M; Yoshitomi H
    Biol Pharm Bull; 2000 Oct; 23(10):1229-34. PubMed ID: 11041257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro conditions for the study of the in vivo performance of sustained-release theophylline matrix tablets administered in fasted conditions and with a high-fat diet.
    Andonaegui MT; Barría JL; Thielemann AM; Seitz C; Gai MN
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1199-203. PubMed ID: 10596358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new drug delivery system using plasma-irradiated pharmaceutical aids. V. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of a wall material containing polybenzylmethacrylate.
    Ishikawa M; Noguchi T; Niwa J; Kuzuya M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2215-20. PubMed ID: 8582024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of griseofulvin with cyclodextrins in solid binary systems.
    Veiga MD; Díaz PJ; Ahsan F
    J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of naproxen with noncrystalline acetyl beta- and acetyl gamma-cyclodextrins in the solid and liquid state.
    Bettinetti G; Mura P; Faucci MT; Sorrenti M; Setti M
    Eur J Pharm Sci; 2002 Feb; 15(1):21-9. PubMed ID: 11803128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of beta-cyclodextrin on the solubility and dissolution rate of paracetamol solid dispersions.
    Tasić LM; Jovanović MD; Djurić ZR
    J Pharm Pharmacol; 1992 Jan; 44(1):52-5. PubMed ID: 1350629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets.
    Pose-Vilarnovo B; Rodríguez-Tenreiro C; Rosa dos Santos JF; Vázquez-Doval J; Concheiro A; Alvarez-Lorenzo C; Torres-Labandeira JJ
    J Control Release; 2004 Feb; 94(2-3):351-63. PubMed ID: 14744486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.